Barmer founds Institute for Health Systems Research
08.06.2020 10:01
With the newly founded “BARMER Institute for Health System Research” (bifg), BARMER, with its 9.1 million insured people, is institutionalizing the series of health reports it has been publishing for years on topics such as pharmaceuticals, outpatient care (doctor), health, medicines and aids, hospital care and nursing care and dental health. On the one hand, this is intended to further increase the broad impact of the publications and analyzes produced and, on the other hand, to give the research perspective a more independent focus.
Organizationally, the new scientific institute forms an independent unit within BARMER and is headed by graduate economist Uwe Repschläger as managing director. The bifg is divided into three research areas: strategic analyses, health systems research and medicine and health services research. The health services research department, which has eight employees, is headed by Dr. med. Ursula Marschall, specialist in anesthesia and qualified health economist.
The work of the bifg is accompanied by a scientific advisory board, which advises the institute on fundamental scientific questions and supports cooperation with other health care institutions as well as bringing impulses from science and practice into the bifg's research activities. The advisory board includes:
Prof. Dr. Boris Augurtsky (Head of the “Health” competence area at the RWI in Essen, managing director of the Institute for Health Care Business GmbH since 2007 and at the Münch Foundation since 2014, chairman of the board since 2019. In 2016 he was appointed adjunct professor at the University of Duisburg-Essen).
Prof. Dr. Wolfgang Greiner (since April 2005 he has held the chair for “Health Economics and Health Management” at Bielefeld University. Since 2010, Prof. Greiner has been a member of the expert council for assessing developments in the healthcare system Federal Ministry of Health, its deputy chairman since 2019).
Prof. Dr. med. Thomas Mansky (Emeritus and self-employed. From 2010 to 2018 he headed the structural development and quality management department in healthcare at the TU Berlin. From 2000 to 2010 he was the head of the medical development department at the HELIOS clinics).
Prof. Dr. Leonie Sundmacher (has headed the Health Services Management Department at the Faculty of Business Administration at the Ludwig Maximilian University of Munich since October 2013. She studied economics, health economics and political science at the University of York and at the Free University of Berlin and received her doctorate in economics in 2010 at the Technical University of Berlin).
Prof. Dr. Petra A. Thürmann (Specialist in clinical pharmacology, director of the Philipp Klee Institute for Clinical Pharmacology at the Helios University Hospital Wuppertal since 1997 and has held the chair for clinical pharmacology at the University of Witten/Herdecke since 1998)
Prof. Dr. Jürgen Wasem (He has held the Chair of Medical Management at the University of Duisburg-Essen since 2003. Prof. Wasem has been Chairman of the Extended Evaluation Committee for Statutory Medical Care since 2007. Among other things, he was Chairman of the Arbitration Board for Drug Prices from 2015 to 2019 and Chairman from 2009 to 2018 of the Scientific Advisory Board for the further development of risk structure compensation. In 2013/14 he was chairman of the German Society for Health Economics and since 2015 a member of the executive board of the Society for Insurance Science and Design e. V. (GVG). Chairman of the German Society for Health Economics. He is also Since 2015 member of the executive board of the Society for Insurance Science and Design (GVG).